Meds75+ – information regarding the use for persons aged 75+
- Rabeprazolum natricumUsed as "DRUGS FOR ACID RELATED DISORDERS"Class ASuitable for older persons. Over 8 weeks use only for high risk patients. In long term use, may reduce the absorption of calcium and vitamin B12.
- RacecadotrilumClass BThere is a lack of research evidence, clinical experience or efficacy among older persons. For short-term use only.
- RamiprilumClass CSuitable for older persons, with specific cautions. Reduce the dose in even moderate renal insufficiency. Monitor renal function during the pharmacotherapy. Avoid concurrent use of anti-inflammatory analgesics.
- RepaglinidumUsed as "DRUGS USED IN DIABETES"Class DAvoid use in older persons. Risk of hypoglycaemia. Take several interactions into account.
- Retinoli palmitas
- RisperidonumUsed as "PSYCHOLEPTICS"Class CSuitable for older persons, with specific cautions. Regularly assess the need for pharmacotherapy. Reduce the dose in even mild renal insufficiency. Significant adverse effects include cognitive disorder, confusion, extrapyramidal symptoms, orthostatic hypotension and risk of cardiovascular events. Increases risk for falls. Non-pharmacological treatments are the first line approach in the management of behavioral and psychological symptoms of dementia.
- RivaroxabanumUsed as "ANTITHROMBOTIC AGENTS"Class CSuitable for older persons, with specific cautions. Reduce the dose in even moderate renal insufficiency. A significant adverse effect is increased risk of bleeding. Take interactions into account. Andexanet alfa can be used as an antidote.
- RivastigminumUsed as "PSYCHOANALEPTICS"Class CSuitable for older persons, with specific cautions. May exacerbate an existing COPD. Predisposes to cardiac conduction disorders, such as bradycardia. Note adverse effects affecting the gastrointestinal tract. Take interactions into account. Anticholinergic drugs weakens the efficacy of anti-Alzheimer´s drugs.
Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.
Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.
Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.
Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.